Tango Therapeutics TNGX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Tango Therapeutics (TNGX) reported comprehensive income (loss), net of tax, attributable to parent of -$45.85M in Q1 2026.
- How has Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 14.6% year-over-year, from -$40.02M to -$45.85M.
- What is the long-term trend for Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 14.6% compound annual growth rate (CAGR), from -$59.02M to -$101.71M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures changes in equity resulting from transactions and economic events other than those from transactions with owners. It includes unrealized gains or losses on available-for-sale securities, foreign currency translation adjustments, and other items that bypass the traditional net income statement. It provides a more holistic view of a company's financial health by accounting for volatility in asset valuations.